These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32416673)

  • 41. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
    Luo HS; Wu DH
    Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tenascin-C, a Prognostic Determinant of Esophageal Squamous Cell Carcinoma.
    Yang ZT; Yeo SY; Yin YX; Lin ZH; Lee HM; Xuan YH; Cui Y; Kim SH
    PLoS One; 2016; 11(1):e0145807. PubMed ID: 26731558
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Expression of fibronectin in esophageal squamous cell carcinoma and its role in migration.
    Xiao J; Yang W; Xu B; Zhu H; Zou J; Su C; Rong J; Wang T; Chen Z
    BMC Cancer; 2018 Oct; 18(1):976. PubMed ID: 30314454
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cytoplasmic collagen XIαI as a prognostic biomarker in esophageal squamous cell carcinoma.
    Zhang B; Zhang C; Yang X; Chen Y; Zhang H; Liu J; Wu Q
    Cancer Biol Ther; 2018 May; 19(5):364-372. PubMed ID: 29333916
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
    Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
    Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
    Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
    Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LRRC8A Expression Influences Growth of Esophageal Squamous Cell Carcinoma.
    Konishi T; Shiozaki A; Kosuga T; Kudou M; Shoda K; Arita T; Konishi H; Komatsu S; Kubota T; Fujiwara H; Okamoto K; Kishimoto M; Konishi E; Marunaka Y; Otsuji E
    Am J Pathol; 2019 Oct; 189(10):1973-1985. PubMed ID: 31323188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-153-3p regulates cell proliferation and cisplatin resistance via Nrf-2 in esophageal squamous cell carcinoma.
    Zuo J; Zhao M; Fan Z; Liu B; Wang Y; Li Y; Lv P; Xing L; Zhang X; Shen H
    Thorac Cancer; 2020 Mar; 11(3):738-747. PubMed ID: 32012470
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epigenetically upregulated oncoprotein PLCE1 drives esophageal carcinoma angiogenesis and proliferation via activating the PI-PLCε-NF-κB signaling pathway and VEGF-C/ Bcl-2 expression.
    Chen Y; Wang D; Peng H; Chen X; Han X; Yu J; Wang W; Liang L; Liu Z; Zheng Y; Hu J; Yang L; Li J; Zhou H; Cui X; Li F
    Mol Cancer; 2019 Jan; 18(1):1. PubMed ID: 30609930
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
    Sun J; Song K; Feng X; Gao S
    Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Nuclear Localization of DNAJB6 Is Associated With Survival of Patients With Esophageal Cancer and Reduces AKT Signaling and Proliferation of Cancer Cells.
    Yu VZ; Wong VC; Dai W; Ko JM; Lam AK; Chan KW; Samant RS; Lung HL; Shuen WH; Law S; Chan YP; Lee NP; Tong DK; Law TT; Lee VH; Lung ML
    Gastroenterology; 2015 Dec; 149(7):1825-1836.e5. PubMed ID: 26302489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overexpression of HSP47 in esophageal squamous cell carcinoma: clinical implications and functional analysis.
    Lee HW; Kwon J; Kang MC; Noh MK; Koh JS; Kim JH; Park JH
    Dis Esophagus; 2016 Oct; 29(7):848-855. PubMed ID: 25953518
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Musashi1, a potential prognostic marker in esophageal squamous cell carcinoma.
    Qin G; Lian J; Yue D; Chen X; Nan S; Qi Y; Li B; Cui G; Li X; Zhao S; Zhang Y
    Oncol Rep; 2017 Sep; 38(3):1724-1732. PubMed ID: 28713964
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Overexpression of Cullin4A correlates with a poor prognosis and tumor progression in esophageal squamous cell carcinoma.
    Nakade H; Migita K; Matsumoto S; Wakatsuki K; Kunishige T; Miyao S; Sho M
    Int J Clin Oncol; 2020 Mar; 25(3):446-455. PubMed ID: 31535245
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A six-microRNA risk score model predicts prognosis in esophageal squamous cell carcinoma.
    Mao Y; Fu Z; Zhang Y; Dong L; Zhang Y; Zhang Q; Li X; Wang C
    J Cell Physiol; 2019 May; 234(5):6810-6819. PubMed ID: 30387125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serum levels of miRNA-183 in patients with esophageal squamous cell carcinoma and its diagnostic value].
    Chen J; Chen M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 43(10):1048-1053. PubMed ID: 30523223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pristimerin targeting NF-κB pathway inhibits proliferation, migration, and invasion in esophageal squamous cell carcinoma cells.
    Tu Y; Tan F; Zhou J; Pan J
    Cell Biochem Funct; 2018 Jun; 36(4):228-240. PubMed ID: 29781107
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.